{"id":"NCT03262012","sponsor":"Pearl Therapeutics, Inc.","briefTitle":"Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®","officialTitle":"A Randomized, Double-Blind, Parallel-Group, 28-Week, Chronic-Dosing, Multi-Center, Extension Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) Compared With Symbicort® Turbuhaler® as an Active Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-09","primaryCompletion":"2018-06-15","completion":"2018-06-15","firstPosted":"2017-08-25","resultsPosted":"2020-05-13","lastUpdate":"2020-05-13"},"enrollment":416,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["COPD"],"interventions":[{"type":"DRUG","name":"BGF MDI (PT010)","otherNames":["BGF"]},{"type":"DRUG","name":"GFF MDI (PT003)","otherNames":["GFF"]},{"type":"DRUG","name":"BFF MDI (PT009)","otherNames":["BFF"]},{"type":"DRUG","name":"Symbicort® Turbohaler® Inhalation Powder","otherNames":["Symbicort"]}],"arms":[{"label":"BGF MDI (PT010)","type":"EXPERIMENTAL"},{"label":"GFF MDI (PT003)","type":"EXPERIMENTAL"},{"label":"BFF MDI (PT009)","type":"EXPERIMENTAL"},{"label":"Symbicort® Turbohaler® Inhalation Powder","type":"ACTIVE_COMPARATOR"}],"summary":"A Randomized, Double-Blind, Parallel Group, 28-Week Chronic Dosing, Multi-Center Long-term Extension Study to Assess the Safety and Efficacy in Japanese Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) compared with Symbicort® Turbohaler®","primaryOutcome":{"measure":"Incidence of Post-baseline Newly Occurring or Worsening PCS (Potentially Clinically Significant) Clinical Chemistry Values","timeFrame":"28 Weeks","effectByArm":[{"arm":"BGF MDI 320/14.4/9.6 ug","deltaMin":0,"sd":null},{"arm":"GFF MDI 14.4/9.6 ug","deltaMin":1,"sd":null},{"arm":"BFF MDI 320/9.6 ug","deltaMin":0,"sd":null},{"arm":"Symbicort TBH 400/12 ug","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":8},"locations":{"siteCount":79,"countries":["Japan"]},"refs":{"pmids":["35815359"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":139},"commonTop":["Nasopharyngitis","Bronchitis","Muscle spasms","Dysphonia","Upper respiratory tract infection"]}}